Country Report: Belgium
Belgium is a hub for clinical trials, a leader in the biopharmaceutical industry, and a center for pharmaceutical production and distribution.
On-Market Pricing Strategies
List pricing strategies that diverge from these approaches without "hitting the cliff".
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?
The European Union's attempt to update its transparency rules sparks new debate.
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumph
The slow evolution toward a state of grace in tracking ROI for digital promotion.
PE, April 2013 Cover Image
S
Pfizer's Quality by Design Approach to Trial Management
Improving the quality of clinical trials is a major strategic activity for Big Pharma, one where efficient management of a demanding set of regulatory requirements can have a positive impact on the bottom line.
2013 Dealmakers Outlook
Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.
Woman of the Year 2013
This year's HBA Woman of the Year is Merck's Bridgette Heller of Merck Consumer Care.
Key to Brand Positioning: Look Inside Your Heart
Take a page from the consumer marketing playbook and promote a product's advantage and why it should matter to the customer.
The Community Clause
The conversation thread that binds this month's Pharm Exec is building communities-when the harsh economics of market change suddenly discounts the familiar, then the best way to move up is to reach out.
Conflicted Interest
Do Big Pharma dollars make physicians lousy caregivers?
Full Disclosure for Pharma
There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices.
